In consultation: Guidance and quality standards
Showing 1 to 1 of 1
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (MA review of HST12) [ID6145] | Draft guidance | Highly specialised technology |